Cefuroxime

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Older cephalosporin.

Half-lifeThis section has been translated automatically.

1–2 h

Spectrum of actionThis section has been translated automatically.

Branhamella catarrhalis, Enterobacter sakazakii, E. coli, Haemophilus spp., Hafnia alvei, Klebsiella spp., Neisseria gonorrhoeae, Proteus mirabilis, Providenia spp., Salmonella spp., Shigella spp., Staphylococcus spp.

IndicationThis section has been translated automatically.

Respiratory tract, urinary tract, skin and soft tissue infections, acute uncomplicated gonorrhoea.

Dosage and method of useThis section has been translated automatically.

  • 2-3 times 750-1,500 mg/day i.v.
  • Children: 50-100 mg/kg bw/day in 3 sessions.
  • Gonorrhoea: 1500 mg in 2 sessions of 750 mg each, bilaterally intraglutaeally.

PreparationsThis section has been translated automatically.

Cefuroxime, Elobact, Zinacef, Tinate

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer